Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1978 ARTÍCULOS , VIENDO DEL 1546 AL 1560

Transfer Learning for Alzheimer's Disease through Neuroimaging Biomarkers: A Systematic Review

Agarwal D, Marques G, de la Torre-Díez I, Franco Martin MA, García Zapiraín B, Martín Rodríguez F.

Sensors (Basel). 2021 Oct 31;21(21):7259. doi: 10.3390/s21217259.

Association of tear fluid amyloid and tau levels with disease severity and neurodegeneration

Gijs M, Ramakers IHGB, Visser PJ, Verhey FRJ, van de Waarenburg MPH, Schalkwijk CG, Nuijts RMMA, Webers CAB.

Sci Rep. 2021 Nov 22;11(1):22675. doi: 10.1038/s41598-021-01993-x.

Iron Homeostasis Disorder and Alzheimer's Disease

Peng Y, Chang X, Lang M.

Int J Mol Sci. 2021 Nov 18;22(22):12442. doi: 10.3390/ijms222212442.

Tau Biomarkers in Dementia: Positron Emission Tomography Radiopharmaceuticals in Tauopathy Assessment and Future Perspective

Ricci M, Cimini A, Camedda R, Chiaravalloti A, Schillaci O.

Int J Mol Sci. 2021 Nov 30;22(23):13002. doi: 10.3390/ijms222313002.

miRNAs as Therapeutic Tools in Alzheimer's Disease

Lee CY, Ryu IS, Ryu JH, Cho HJ.

Int J Mol Sci. 2021 Dec 1;22(23):13012. doi: 10.3390/ijms222313012.

Molecular Aspects of Cellular Dysfunction in Alzheimer's Disease: The Need for a Holistic View of the Early Pathogenesis

Merlo S, Spampinato SF, Lim D.

Biomolecules. 2021 Dec 1;11(12):1807. doi: 10.3390/biom11121807.

A case report of late-onset schizophrenia differentiated from a dementing disorder

Shimada T, Uehara T, Nagasawa T, Hasegawa M, Maeda Y, Kawasaki Y.

Neurocase. 2021 Dec;27(6):467-473. doi: 10.1080/13554794.2021.2016858. Epub 2021 Dec 23.

YKL-40 as a Potential Biomarker for the Differential Diagnosis of Alzheimer's Disease

Mavroudis I, Chowdhury R, Petridis F, Karantali E, Chatzikonstantinou S, Balmus IM, Luca IS, Ciobica A, Kazis D.

Medicina (Kaunas). 2021 Dec 30;58(1):60. doi: 10.3390/medicina58010060.

Awareness in severe Alzheimer's disease: a systematic review

O'Shaughnessy NJ, Chan JE, Bhome R, Gallagher P, Zhang H, Clare L, Sampson EL, Stone P, Huntley J.

Aging Ment Health. 2021 Apr;25(4):602-612. doi: 10.1080/13607863.2020.1711859. Epub 2020 Jan 16.

Mitochondria-Targeted Therapeutics for Alzheimer's Disease: The Good, the Bad, the Potential

Mi Y, Qi G, Brinton RD, Yin F.

Antioxid Redox Signal. 2021 Mar 10;34(8):611-630. doi: 10.1089/ars.2020.8070. Epub 2020 Apr 21.

The β-Secretase BACE1 in Alzheimer's Disease

Hampel H, Vassar R, De Strooper B, Hardy J, Willem M, Singh N, Zhou J, Yan R, Vanmechelen E, De Vos A, Nisticò R, Corbo M, Imbimbo BP, Streffer J, Voytyuk I, Timmers M, Tahami Monfared AA, Irizarry M, Albala B, Koyama A, Watanabe N, Kimura T, Yarenis L, Lista S, Kramer L, Vergallo A.

Biol Psychiatry. 2021 Apr 15;89(8):745-756. doi: 10.1016/j.biopsych.2020.02.001. Epub 2020 Feb 13.

Melatonin effects on EEG activity during non-rapid eye movement sleep in mild-to-moderate Alzheimer´s disease: a pilot study

Cruz-Aguilar MA, Ramírez-Salado I, Hernández-González M, Guevara MA, Del Río JM.

Int J Neurosci. 2021 Jun;131(6):580-590. doi: 10.1080/00207454.2020.1750392. Epub 2020 Apr 13.

Extracellular Zn(2+)-Dependent Amyloid-β(1-42) Neurotoxicity in Alzheimer's Disease Pathogenesis

Sato Y, Takiguchi M, Tamano H, Takeda A.

Biol Trace Elem Res. 2021 Jan;199(1):53-61. doi: 10.1007/s12011-020-02131-w. Epub 2020 Apr 13.

Effects of short- and long-term neurostimulation (tDCS) on Alzheimer's disease patients: two randomized studies

Gangemi A, Colombo B, Fabio RA.

Aging Clin Exp Res. 2021 Feb;33(2):383-390. doi: 10.1007/s40520-020-01546-8. Epub 2020 Apr 16.

Apolipoprotein E4 and meningeal lymphatics in Alzheimer disease: a conceptual framework

Mentis AA, Dardiotis E, Chrousos GP.

Mol Psychiatry. 2021 Apr;26(4):1075-1097. doi: 10.1038/s41380-020-0731-7. Epub 2020 Apr 30.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias